Coffin-Siris syndrome - one syndrome with various genetic variants and phenotypes

Authors

DOI:

https://doi.org/10.15574/SP.2024.139.123

Keywords:

Coffin-Siris syndrome, phenotype, SMARCA4, DPF2, developmental delay, rare diseases, children

Abstract

Coffin-Siris syndrome encompasses a group of genetic disorders with a wide spectrum of phenotypic features, characterized by varying degrees of intellectual disability, developmental delay, and other clinical signs. Among the most common features are the aplasia or hypoplasia of the distal phalanx or nail of the fifth finger and coarse facial features.

The aim of the work is to increase awareness among physicians about the diagnosis of Coffin-Siris syndrome and expand knowledge of the spectrum of clinical features of the disease based on the presentation of two clinical cases.

We presented two clinical cases of Coffin-Siris syndrome caused by variants in the SMARCA4 and DPF2 genes. In both cases, there is a delay in speech development, cognitive impairments of varying severity, behavioral changes, characteristic dysmorphic features, and changes in the hands and/or feet, especially in the little finger. Distal phalanx nail hypoplasia of the fifth finger was present in the case associated with a variant in the DPF2 gene. In the patient with a variant in the SMARCA4 gene, flexion deformity of the little finger and broad palms were observed. Pachydermodactyly and a congenital kidney defect were also diagnosed in this patient.

Thus, genetic diagnosis allows for timely identification, preventing complications and avoiding unnecessary investigations. Accumulating clinical data on rare diseases and their systematization contribute to research development and, subsequently, to determining optimal therapeutic approaches. The identified genetic factor in the proband ensures genetic counseling for the family and determining risk indicators for pathologies in offspring.

The research was carried out in accordance with the principles of the Helsinki Declaration. The informed consent of the patient was obtained for conducting the studies.

No conflict of interests was declared by the authors.

Author Biography

H.V. Makukh, LeoGEN Scientific Medical Genetic Center, Lviv

Regional Center of Neonatal Screening, Municipal Non-Profit Enterprise "Lviv Regional Clinical Perinatal Center", Ukraine

References

Bögershausen N, Wollnik B. (2018). Mutational Landscapes and Phenotypic Spectrum of SWI/SNF-Related Intellectual Disability Disorders. Front Mol Neurosci. 11: 252. https://doi.org/10.3389/fnmol.2018.00252; PMid:30123105 PMCid:PMC6085491

Boyarchuk O, Kinash M, Hariyan T, Bakalyuk T. (2019). Evaluation of knowledge about primary immunodeficiencies among postgraduate medical students. Archives of the Balkan Medical Union. 54(1): 11-19. https://doi.org/10.31688/ABMU.2019.54.1.18

Boyarchuk O, Volyanska L, Kosovska T, Lewandowicz-Uszynska A, Kinash M. (2018). Awareness of primary immunodeficiency diseases among medical students. Georgian Med News. 285: 124-130.

Knapp KM, Poke G, Jenkins D, Truter W, Bicknell LS. (2019). Expanding the phenotypic spectrum associated with DPF2: A new case report. Am J Med Genet A. 179(8): 1637-1641. https://doi.org/10.1002/ajmg.a.61262; PMid:31207137

Li D, Ahrens-Nicklas RC, Baker J, Bhambhani V, Calhoun A, Cohen JS et al. (2020). The variability of SMARCA4-related Coffin-Siris syndrome: Do nonsense candidate variants add to milder phenotypes? Am J Med Genet A. 182(9): 2058-2067. https://doi.org/10.1002/ajmg.a.61732; PMid:32686290

Mardinian K, Adashek JJ, Botta GP, Kato S, Kurzrock R.(2021). SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy. Mol Cancer Ther. 20(12): 2341-2351. https://doi.org/10.1158/1535-7163.MCT-21-0433; PMid:34642211 PMCid:PMC8643328

McKnight D, Morales A, Hatchell KE, Bristow SL, Bonkowsky JL, Perry MS et al. (2022). Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice. JAMA Neurol. 79(12): 1267-1276. https://doi.org/10.1001/jamaneurol.2022.3651; PMid:36315135 PMCid:PMC9623482

Schmetz A, Lüdecke HJ, Surowy H, Sivalingam S, Bruel AL, Caumes R et al.(2024). Delineation of the adult phenotype of Coffin-Siris syndrome in 35 individuals. Hum Genet. 143(1): 71-84. https://doi.org/10.1007/s00439-023-02622-5; PMid:38117302

Van der Sluijs PJ, Jansen S, Vergano SA, Adachi-Fukuda M, Alanay Y, AlKindy A et al. (2019). The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin-Siris syndrome. Genet Med. 21(6): 1295-1307. https://doi.org/10.1038/s41436-018-0330-z; PMid:30349098 PMCid:PMC6752273

Vasileiou G, Vergarajauregui S, Endele S, Popp B, Büttner C, Ekici AB et al. (2018). Mutations in the BAF-Complex Subunit DPF2 Are Associated with Coffin-Siris Syndrome. Am J Hum Genet. 102(3): 468-479. https://doi.org/10.1016/j.ajhg.2018.01.014; PMid:29429572 PMCid:PMC5985265

Vasko A, Drivas TG, Schrier Vergano SA. (2021). Genotype-Phenotype Correlations in 208 Individuals with Coffin-Siris Syndrome. Genes (Basel). 12(6): 937. https://doi.org/10.3390/genes12060937; PMid:34205270 PMCid:PMC8233770

Witkowski L, Donini N, Byler-Dann R, Knost JA, Albrecht S, Berchuck A, et al. (2017). The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases. Fam Cancer. 16(3): 395-399. https://doi.org/10.1007/s10689-016-9957-6; PMid:27866340 PMCid:PMC5487815

Published

2024-04-28